Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,Candidiasis,Inverse variance weighted,23,0.99 [0.87-1.12],0.840236490392151
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,23,1.02 [0.97-1.07],0.425261058137284
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,23,1.01 [0.97-1.06],0.546735239692347
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,Mycoses,Inverse variance weighted,23,0.96 [0.88-1.05],0.419316103858051
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,23,1.03 [0.98-1.07],0.236194665242415
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,23,1.13 [0.70-1.82],0.624120270073786
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,23,1.02 [0.94-1.11],0.605373513840248
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,Other viral diseases,Inverse variance weighted,23,0.97 [0.88-1.06],0.458378277881413
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,23,1.26 [0.98-1.62],0.0686806562149899
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,23,1.12 [0.97-1.30],0.116713989784544
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,23,1.09 [0.87-1.37],0.450059907107272
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Crohn's disease NAS,Inverse variance weighted,23,1.03 [0.86-1.22],0.764392507697064
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Early onset COPD,Inverse variance weighted,23,1.11 [1.01-1.22],0.0275274842891559
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Later onset COPD,Inverse variance weighted,23,1.05 [0.94-1.17],0.417506917097061
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,Inverse variance weighted,23,1.03 [0.75-1.41],0.858140133798933
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,23,1.06 [0.98-1.14],0.173752200788803
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,23,1.02 [0.96-1.10],0.502848961158476
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,Inverse variance weighted,23,1.15 [0.72-1.82],0.557638302989748
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,Inverse variance weighted,23,1.01 [0.89-1.14],0.935324770946425
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,Inverse variance weighted,23,0.94 [0.83-1.06],0.338553919914058
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,Inverse variance weighted,23,1.14 [0.77-1.71],0.507263262582925
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",Inverse variance weighted,23,1.07 [0.88-1.31],0.486649274591594
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,23,0.74 [0.52-1.05],0.0902638650987059
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,Inverse variance weighted,23,1.06 [0.68-1.65],0.797208012764294
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,23,1.03 [0.95-1.12],0.457137288761231
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,23,1.10 [0.94-1.28],0.238602462287564
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,23,0.98 [0.79-1.22],0.863484655530151
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,Inverse variance weighted,23,1.11 [0.97-1.28],0.137444047208274
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,Inverse variance weighted,23,1.02 [0.92-1.14],0.691503401974509
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,Inverse variance weighted,23,0.77 [0.50-1.18],0.224343283261019
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,23,0.96 [0.92-1.01],0.132594682366129
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,23,0.98 [0.94-1.02],0.299908072687689
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,Inverse variance weighted,23,0.99 [0.51-1.92],0.968066221108428
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,Inverse variance weighted,23,0.90 [0.75-1.07],0.233051937421917
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,23,1.00 [0.96-1.04],0.964781211585575
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,Inverse variance weighted,23,0.94 [0.61-1.45],0.772771662740217
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,23,0.97 [0.83-1.13],0.675221604830424
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",Inverse variance weighted,23,0.96 [0.83-1.10],0.52660876611898
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,Inverse variance weighted,23,1.01 [0.96-1.06],0.695423762080926
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,Inverse variance weighted,23,0.99 [0.94-1.03],0.546249208892183
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,Falls/tendency to fall,Inverse variance weighted,23,1.01 [0.98-1.05],0.440513729146855
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,Inverse variance weighted,23,0.98 [0.86-1.12],0.790986804283346
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,Hemiplegia,Inverse variance weighted,23,1.02 [0.83-1.24],0.871349751133605
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,Inverse variance weighted,23,1.04 [0.99-1.09],0.0907143300668024
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),Inverse variance weighted,23,0.93 [0.80-1.08],0.349242720071457
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,23,0.99 [0.92-1.06],0.75658027339125
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Angina pectoris,Inverse variance weighted,23,1.01 [0.95-1.08],0.663911384013465
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Aortic aneurysm,Inverse variance weighted,23,0.96 [0.87-1.07],0.487473605936161
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,Inverse variance weighted,23,0.99 [0.74-1.32],0.92723061438263
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,Inverse variance weighted,23,0.88 [0.66-1.18],0.402467091956986
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,Inverse variance weighted,23,1.05 [0.87-1.25],0.625004344497849
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,23,0.99 [0.93-1.06],0.83940733351386
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Cardiac arrest,Inverse variance weighted,23,0.94 [0.78-1.13],0.504685865935355
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",Inverse variance weighted,23,0.88 [0.74-1.05],0.159311326548531
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Conduction disorders,Inverse variance weighted,23,0.99 [0.92-1.08],0.87437167401691
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,23,1.00 [0.95-1.06],0.903480709287891
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,23,0.98 [0.92-1.04],0.484627623326841
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,23,1.01 [0.90-1.14],0.81085715139376
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,23,1.01 [0.97-1.05],0.642497250853197
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,23,1.01 [0.96-1.05],0.770417495377757
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",Inverse variance weighted,23,0.77 [0.47-1.28],0.317576890931532
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,23,1.02 [0.79-1.30],0.895741561575979
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,23,1.01 [0.97-1.06],0.560761896976117
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,23,1.00 [0.93-1.09],0.921073320576679
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Left bundle-branch block,Inverse variance weighted,23,0.89 [0.74-1.06],0.188816915064611
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",Inverse variance weighted,23,1.01 [0.94-1.09],0.816544141194809
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,23,1.11 [0.91-1.36],0.300184804089033
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,23,1.02 [0.80-1.30],0.897528667561251
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,23,0.84 [0.69-1.03],0.0869200206932886
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,Inverse variance weighted,23,1.04 [0.94-1.14],0.458311700760254
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Right bundle-branch block,Inverse variance weighted,23,0.90 [0.70-1.15],0.396416060631616
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,Inverse variance weighted,23,1.08 [0.75-1.56],0.687592359853701
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,23,0.90 [0.71-1.13],0.362110231352312
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,Inverse variance weighted,23,0.91 [0.84-0.98],0.0102184651356616
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,Oesophageal varices,Inverse variance weighted,23,1.14 [0.90-1.46],0.276836575992992
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,23,0.99 [0.88-1.11],0.838375558571649
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),Inverse variance weighted,23,0.94 [0.84-1.05],0.24370387439209
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,Inverse variance weighted,23,1.14 [0.96-1.35],0.149083302877921
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,23,0.96 [0.83-1.12],0.634157589231702
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Bronchiectasis,Inverse variance weighted,23,1.05 [0.85-1.29],0.6566139958802
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Emphysema,Inverse variance weighted,23,1.18 [0.98-1.41],0.0733663097751897
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,Inverse variance weighted,23,1.03 [0.90-1.18],0.628220947127107
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,All influenza,Inverse variance weighted,23,0.93 [0.85-1.01],0.0922487679493516
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,23,1.00 [0.96-1.04],0.977141732395793
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,23,1.00 [0.96-1.03],0.844168671689047
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,23,1.03 [0.97-1.09],0.32431416695177
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,23,1.04 [0.97-1.11],0.243587163531371
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,23,1.12 [0.97-1.29],0.128102247897302
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,Inverse variance weighted,23,1.03 [0.87-1.21],0.757265963086117
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,Pneumothorax,Inverse variance weighted,23,0.93 [0.78-1.10],0.390171779664726
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Alcoholic liver disease,Inverse variance weighted,23,1.09 [0.94-1.26],0.249638214692813
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Cholelithiasis,Inverse variance weighted,23,0.98 [0.94-1.03],0.397198942074419
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Coeliac disease,Inverse variance weighted,23,1.04 [0.91-1.19],0.569479303264631
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Constipation,Inverse variance weighted,23,0.96 [0.92-1.01],0.0829947923314859
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,23,1.00 [0.88-1.13],0.944245728992756
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,23,0.96 [0.78-1.18],0.69647646369618
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",Inverse variance weighted,23,1.15 [0.84-1.59],0.382145703939071
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Other diseases of intestines,Inverse variance weighted,23,1.04 [1.00-1.08],0.0705923248197369
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,23,1.05 [0.96-1.14],0.304865955277602
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Intestinal malabsorption,Inverse variance weighted,23,0.96 [0.76-1.20],0.70186063273098
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,23,0.99 [0.96-1.03],0.64015587076855
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Diseases of the digestive system,Inverse variance weighted,23,1.04 [0.97-1.11],0.312983888339176
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,Inverse variance weighted,23,1.04 [0.95-1.13],0.416414575185163
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,Inverse variance weighted,23,1.06 [0.92-1.22],0.435409035719217
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,Inverse variance weighted,23,1.25 [1.04-1.50],0.0184140007767301
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,Inverse variance weighted,23,1.04 [0.96-1.13],0.310510911326215
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),Inverse variance weighted,23,1.03 [0.94-1.14],0.505903151622455
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,Inverse variance weighted,23,1.07 [0.89-1.29],0.46946079258053
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Other diseases of intestine,Inverse variance weighted,23,1.12 [0.97-1.28],0.116162287773071
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,Inverse variance weighted,23,0.98 [0.93-1.04],0.541390465210078
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,23,0.98 [0.94-1.02],0.296704442095696
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",Inverse variance weighted,23,0.96 [0.91-1.02],0.15152328804118
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,23,0.94 [0.85-1.03],0.201694039721695
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,Inverse variance weighted,23,1.20 [0.98-1.47],0.0774157613022254
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,Inverse variance weighted,23,1.04 [1.00-1.08],0.0556930251771245
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,23,1.01 [0.95-1.08],0.673383778155673
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,Inverse variance weighted,23,1.20 [0.89-1.63],0.233770775041783
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,23,1.02 [0.97-1.07],0.4656376786261
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,Inverse variance weighted,23,1.01 [0.87-1.18],0.883325942006895
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,23,1.08 [0.95-1.23],0.229197526562924
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,Inverse variance weighted,23,1.05 [0.77-1.43],0.752467207554476
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,23,0.94 [0.87-1.03],0.202311489445595
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,Inverse variance weighted,23,0.98 [0.91-1.05],0.551656595937869
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,Inverse variance weighted,23,0.97 [0.88-1.06],0.4818772220107
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,23,1.05 [1.00-1.10],0.05030980711665
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,23,1.13 [1.01-1.26],0.034620232655279
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [SjÂšgren],Inverse variance weighted,23,0.99 [0.85-1.16],0.92880396578093
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",Inverse variance weighted,23,1.03 [0.97-1.08],0.35408334986404
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,23,0.98 [0.89-1.09],0.707201411386142
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,23,1.22 [0.97-1.54],0.0911616013192356
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,23,0.98 [0.89-1.07],0.661763279398193
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,23,0.99 [0.78-1.27],0.943950443228274
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,23,1.06 [0.91-1.24],0.419786374034042
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,23,0.98 [0.93-1.02],0.330173440198448
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,23,0.97 [0.83-1.13],0.70256020753861
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,23,0.98 [0.93-1.04],0.497088275367521
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,Inverse variance weighted,23,0.98 [0.94-1.02],0.240182802326895
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,Inverse variance weighted,23,0.96 [0.79-1.17],0.684556210706394
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,23,1.11 [0.93-1.32],0.260767492644528
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,23,1.15 [1.03-1.30],0.0174126344251717
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,Smoking dependency,Inverse variance weighted,23,1.16 [0.97-1.38],0.0958538904093057
